Key Accounts Prioritize sales efforts with Veterans Affairs, rehabilitation and neuromuscular centers, and PM&R departments that treat peripheral neuropathy and balance disorders. Emphasize Walkasins' clinically proven gait and balance improvements, the device being prescription only requiring clinician involvement, and potential for hospital wide formulary inclusion and device procurement contracts.

Payer Strategy Develop a robust reimbursement plan with Medicare/Medicaid and private insurers by building evidence on fall reduction, improved mobility, and cost savings. Prepare payer ready materials and engage hospital and clinic administrators to explore DME coverage and value based contracts.

Clinician Training Scale adoption through clinician education and certified provider networks; offer onsite training, webinars, and field support to fit into rehab workflows and VA clinics, reducing setup barriers and increasing patient referrals.

Distribution Channels Expand through DME wholesalers, orthotics and prosthetics clinics, and rehab equipment distributors to broaden reach beyond specialty centers and into outpatient and home care settings.

Clinical Partnerships Leverage NIH SBIR-backed credibility to forge research collaborations with academic medical centers and partnerships with other balance/gait training technologies to validate and broaden Walkasins applications, which can drive clinician adoption and payer interest.